Gene Doping Threatens to Transform Sports
Gene Doping Threatens to Transform Sports
“If it does take off, sport as we know it will disappear”
Gene Doping Threatens to Transform Sports
“If it does take off, sport as we know it will disappear”
FDA Acts To Speed Bioterror Medicines
Responding to the threat of anthrax and other forms of chemical and biological terrorism, the Food and Drug Administration adopted new rules yesterday that will speed the approval of drugs that could protect people from attacks.
A Challenge to Science and Nature
A new journal will challenge publishing behemoths such as Science, Nature and Cell by offering free access to research articles immediately upon publication on the Web.
Life after Venter
At Celera Genomics, a new president and questions about the company’s direction.
Biotech heads west for VC
The pot of gold to fund biotech research in Memphis may come from Little Rock
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Recent Comments